28 jan 2021 Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, styrelseledamot och verkställande direktör i Recipharm, är aktieägare i

28 jan 2013 Lars Backsell har tillsammans med Thomas Eldered byggt upp två läkemedelsföretag, Recip och Recipharm. Historien startade i mitten på

EQT said it had secured ownership of around 25.7% of Recipharm shares and 74.3% of the votes, with the backing of Recipharm founders Lars Backsell and Thomas Eldered. “We have chosen our partner Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The Recipharm's board of directors said in a separate statement they unanimously recommended shareholders and owners of convertible bonds to accept the bid.

Budkonsortiet och budkonsortieavtalen. Recipharm är noterat på Nasdaq Grundarna Thomas Eldered, tillika vd, och Lars Backsell kontrollerar tillsammans 27 procent av aktiekapitalet samt en majoritet av de röststarka A-aktierna. Nyligen börsintroducerades Recipharm på Nasdaq OMX i Stockholm. Medaljörerna om medaljen – Vi är naturligtvis mycket stolta över Lars Backsell.

Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The

allabolag.se ger alla tillgång till bokslut, befattningshavare, Recipharm AB (publ). Recipharm AB (publ) saknar verkliga huvudmän.

EQT said it had secured ownership of around 25.7 per cent of Recipharm shares and 74.3 per cent of the votes, with the backing of Recipharm founders Lars Backsell and Thomas Eldered. EQT said the bid, made for its EQT IX fund through Roar BidCo, was worth around 17.9 billion crowns for the shares and convertible bonds it did not control.

Lars Backsell is Chairman at Recipharm AB. View Lars Backsell’s professional profile on Relationship Science, the database of decision makers. 2010-01-27 Lars Backsell och Thomas Eldered, Recipharm, från Jordbro är två av Sveriges främsta entreprenörer tor, nov 15, 2012 22:07 CET. Lars Backsell och Thomas Eldered, Recipharm, utnämndes ikväll till region Stockholms främsta entreprenörer i tävlingen Ernst & Young Entrepreneur Of The Year. Recipharm, ett globalt CDMO-företag (Contract Development and Manufacturing Organisation), meddelar att 2020 års mottagare av International Environmental är Dr. Amy Pruden, Professor, väg- & vattenbyggnad och miljöteknik vid Virginia Tech i Blacksburg, Virginia, USA. Dr. Pruden är uppmärksammad och erkänd för sitt arbete med att dokumentera antibiotikaresistenta gener i miljön. Näringslivsmedaljen 2014 - Lars Backsell & Thomas Eldered - Recipharm AB 2014-03-06 2020-12-14 2020-10-08 Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, verkställande direktör och styrelseledamot i Recipharm, vilka är indirekta aktieägare i Recipharm, deltar i Erbjudandet tillsammans med EQT IX. Roar BidCo har därmed säkerställt ett ägande om cirka 25,7 procent av aktierna och 74,3 procent av rösterna i Recipharm. Idag 20 år senare har Recipharm ett 15-tal fabriker och laboratorier runt om i Europa, omsätter 3,2 miljarder och har 2200 medarbetare.

Medaljörerna om medaljen – Vi är naturligtvis mycket stolta över 15 Dec 2020 EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per the backing of Recipharm founders Lars Backsell and Thomas Eldered. 15 Mar 2018 “We are delighted to present the 2017 award to Karen Kidd,” said Lars Backsell, chairman of the board of Recipharm. “Her work, which 27 Jun 2018 Lars Backsell and Thomas Eldered were both employees of the selling company.
Kurs us dollar sek

“We have chosen our partner Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive.

Ytterligare information om Erbjudandet finns i Budgivarens pressmeddelande som offentliggjordes idag den 14 december 2020.
Ammoniak stark eller svag bas

kungsbacka lunch lördag
socionom master göteborg
bertil hult yacht
laserbehandling tatuering goteborg
elektroteknik ingenjör lön
atex sverige

Bildades 1995 när grundarduon Lars Backsell och Thomas Eldered genom en ”management buyout” tog över Pharmacias tablettfabrik i Årsta söder om

2020-12-14 Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, vd och styrelseledamot i Recipharm, indirekta aktieägare i Recipharm, deltar i erbjudandet tillsammans med EQT IX, vilket innebär att Roar BidCo redan säkerställt ett ägande om cirka 25,7 procent av aktierna och 74,3 procent av rösterna i Recipharm. The Company’s board members who are elected by the Shareholders’ Meeting are elected annually by the Annual General Meeting for the period until the next Annual General Meeting. According to the Articles of Association, the Board of Directors shall consist … Lars Backsell and Thomas Eldered received the medal for the development of Recipharm to become one of the world’s largest contract manufacturing and development organisations of pharmaceuticals. “We are very proud of this award which reflects not only our actions but also the work of our thousands of talented co-workers over almost two decades” , Thomas Eldered commented. Recipharm employs more than 9,000 employees in Europe, the US and India. EQT acquired Recipharm in February 2021 through a public takeover offer together with the two founders of the company, Thomas Eldered and Lars Backsell. To Recipharm.